#atrophy

• Acardiotrophy — Atrophy of the cardiac muscle or a lack of nutritional and structural development of the myocardium, caused by severe vascularization disorders (chronic ischemia), local metabolic deficiencies, or a lack of nervous and endocrine trophic stimulation. This phenomenon leads to the thinning of the heart walls, decrease in cardiac muscle mass, and a drastic reduction in the blood-pumping capacity of the body.
• Acrogeria — A rare congenital structural disorder characterized by premature aging, severe atrophy, and loss of subcutaneous adipose tissue localized exclusively within the extremities (hands and feet), also known as Gottron's syndrome.
• Acrotrophoneurosis — A complex functional and neurovegetative neurological disorder characterized by severe trophic, dystrophic, and vasomotor disturbances localized exclusively within the distal extremities of the body (hands and feet). This structural process alters normal tissue nutrition through the dysfunction of perivascular sympathetic nerve fibers, clinically manifesting as chronic edema, persistent cyanosis (acrocyanosis), skin thinning, keratinization disorders, and altered sensitivity to thermal factors.
• Algoneurosis — A complex neurovegetative and rheumatological condition characterized by chronic and severe pain, local edema, progressive joint stiffness, and severe trophic or vasomotor disturbances of the limb extremities; algodystrophy. The illness is frequently triggered by trauma or fractures.
• Alveolisis — A destructive pathological process consisting of the gradual resorption, atrophy, or destruction of the bony tissue of the alveolar process that supports the teeth in the jaws. This structural osteolytic phenomenon frequently occurs as an advanced complication of periodontal disease (periodontitis) or due to repeated occlusal trauma, leading to progressive tooth mobility and, ultimately, to the loss of the affected tooth.
• Alzheimer's — The name of a progressive and irreversible neurodegenerative disease, representing the most common cause of dementia in older adults, clinically characterized by memory loss, severe cognitive decline, and behavioral changes; a medical eponym structurally named in honor of the German psychiatrist and neuropathologist Alois Alzheimer. This condition is pathologically marked by the accumulation of beta-amyloid plaques and neurofibrillary tangles in brain tissue, leading to neuronal destruction and cortical atrophy.
• Amyosthenia — A functional structural deficiency characterized by pronounced muscle weakness or lack of strength within the skeletal muscles. This pathological condition can be caused by muscle atrophy, metabolic disorders, malnutrition, or prolonged periods of physical immobilization.
• Amyotrophic — Pertaining to amyotrophy or causing progressive loss of muscle mass; characterized by the atrophy of skeletal muscles due to denervation or a neurodegenerative disease. The term is most frequently utilized in clinical pathology to describe amyotrophic lateral sclerosis, a severe condition that selectively destroys motor neurons, disrupting voluntary movement control.
• Amyotrophy — Atrophy or progressive decrease in the volume of muscle mass, caused by a nutritional disorder of the muscles or the loss of normal motor innervation. This pathological structural condition causes severe weakness of the skeletal muscles and is frequently associated with lesions of the spinal cord or peripheral nerves.
• Anatrofion — A pharmaceutical preparation, nutritional supplement, or biological substance with tonic, fortifying, and regenerative properties, historically used to combat malnutrition, physical weakness, or progressive muscular atrophy. This structural compound stimulates cellular metabolic processes of assimilation, favoring the rapid recovery of degraded tissues and restoring the vital strength of a convalescent organism.
• Stiffening process — The act of becoming ankylosed and its result; the pathophysiological process or state through which a joint gradually or totally loses its mobility, becoming rigid due to fibrous or bony transformations.
• Anetoderma — A rare dermatological condition characterized by circumscribed cutaneous atrophy, caused by the localized loss of elastic tissue within the dermis. This structural phenomenon manifests clinically as soft, sac-like lesions that are depressible upon palpation, giving the skin a flaccid appearance resembling an empty pouch, occurring either primarily or secondarily to prior inflammatory processes.
• Atrophy — To undergo a reduction in volume, weight, and functional capacity of an organ, tissue, or the entire body, due to malnutrition, prolonged lack of activity, or aging; (figuratively) to diminish, weaken, or lose original vigor, intensity, or structural value (such as the wasting of talent or feelings).
• Atrophying — Causing or accelerating the process of atrophy; a toxic, degenerative, or pathological factor that leads to a structural diminution of the volume and functional capacity of a tissue or organ. In clinical terms, it describes the destructive evolution of certain dermatological, muscular, or neurological conditions that leave behind tissue underdevelopment sequelae.
• Atrophying — The act of atrophying and its result; the biological or pathological process through which an organ or tissue gradually reduces its volume, weight, and functional capacities. Figuratively, it represents the progressive loss of vigor, intensity, or efficiency of a spiritual faculty, talent, or feeling due to disuse.
• Atrophy — A pathological or physiological diminution of the volume, weight, and functional capacity of an organ, tissue, or component cells, caused by nutritional disorders, prolonged immobilization, denervation, or aging. Figuratively, it represents the weakening, regression, or loss of vigor and efficiency of a spiritual faculty, feeling, or intellectual capacity.
• Atrofo- — A scholarly combining form or prefixoid used to construct medical, biological, or technical terms relating to atrophy, structural degeneration, or lack of nourishment in a tissue or organ. It serves as a functional base to describe pathologies characterized by volume reduction or loss of cellular vitality.
• Atrophoderma — A chronic dermatological condition characterized by the atrophy, thinning, and loss of elasticity of the skin, resulting in a depressed, flaccid, or wrinkled appearance of the affected areas. This structural process destroys collagen and elastin within the dermis, often associated with autoimmune diseases, local vascular disorders, or idiopathic premature aging.